Kevin Coombes Selected Research

Kevin Coombes Research Topics

Disease

17	Neoplasms (Cancer) 10/2020 - 06/2003
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 08/2011
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2017 - 03/2008
4	Breast Neoplasms (Breast Cancer) 12/2010 - 05/2005
3	Neoplasm Metastasis (Metastasis) 10/2020 - 06/2009
3	Carcinogenesis 02/2018 - 02/2006
3	Lung Neoplasms (Lung Cancer) 01/2017 - 09/2013
1	follicular Thyroid cancer 10/2020
1	Thyroid Neoplasms (Thyroid Cancer) 10/2020
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 02/2018
1	Neoplastic Processes 02/2018
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2017
1	Hypersensitivity (Allergy) 01/2017
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2016
1	Hypoxia (Hypoxemia) 08/2011
1	Uveal melanoma 03/2008
1	Chromosome Aberrations (Chromosome Abnormalities) 03/2008
1	Prostatic Neoplasms (Prostate Cancer) 01/2008
1	Glioblastoma (Glioblastoma Multiforme) 01/2008
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2007
1	Mouth Neoplasms (Oral Cancer) 05/2007

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 10/2020 - 12/2010
5	Biomarkers (Surrogate Marker)IBA 01/2016 - 01/2008
4	Complementary DNA (cDNA)IBA 05/2007 - 06/2003
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2012 - 02/2006
2	Estrogen ReceptorsIBA 06/2009 - 05/2005
2	RNA (Ribonucleic Acid)IBA 08/2005 - 01/2004
1	Protein Isoforms (Isoforms)IBA 10/2020
1	RacivirIBA 10/2020
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 10/2020
1	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 10/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2018
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2018
1	villinIBA 02/2018
1	Histones (Histone)IBA 01/2017
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2017
1	Cathepsin GIBA 01/2017
1	taxaneIBA 01/2017
1	P-2 (P 2)IBA 01/2017
1	Atorvastatin (Lipitor)FDA Link 01/2016
1	Drug CombinationsIBA 01/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016
1	ErbB Receptors (EGF Receptor)IBA 06/2015
1	Phosphatidylinositols (Phosphatidylinositol)IBA 09/2013
1	MK 2206IBA 09/2013
1	Arsenic Trioxide (Trisenox)FDA Link 01/2012
1	PlatinumIBA 08/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2011
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 08/2011
1	AntibodiesIBA 12/2010
1	ProteomeIBA 12/2010
1	lysophosphatidic acidIBA 06/2009
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 06/2009
1	Lysophosphatidic Acid ReceptorsIBA 06/2009
1	EnzymesIBA 06/2009
1	Protons (Proton)IBA 03/2008
1	MicroRNAs (MicroRNA)IBA 03/2008
1	Cell Cycle ProteinsIBA 01/2008
1	DNA (Deoxyribonucleic Acid)IBA 01/2008
1	FenretinideIBA 02/2006
1	N-(4-methoxyphenyl)retinamideIBA 02/2006
1	RetinoidsIBA 02/2006
1	Formaldehyde (Formol)FDA Link 05/2005
1	ParaffinIBA 05/2005
1	Tamoxifen FDA LinkGeneric 05/2005
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 05/2005
1	OligonucleotidesIBA 01/2004
1	Transcription Factors (Transcription Factor)IBA 06/2003

Therapy/Procedure

7	Therapeutics 01/2016 - 05/2005
3	Drug Therapy (Chemotherapy) 01/2017 - 05/2005
2	Chemoprevention 02/2018 - 02/2006
2	Radiotherapy 03/2008 - 03/2006
1	Cell Transplantation 01/2016
1	Hematopoietic Stem Cell Transplantation 01/2016
1	Adjuvant Chemotherapy 08/2011
1	Proton Therapy 03/2008
1	Prostatectomy (Retropubic Prostatectomy) 01/2008